Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
100282-49-3
1736-43-2
2366-82-7
537-83-7
1087797-90-7
1087788-56-4
925407-36-9 | 2-chloro-1-[4-(3,4-dimethoxybenzenesulfonyl)piperazin-1-yl]ethan-1-one | AA019P5M | MFCD05862826
875858-81-4 | 2-(4-fluorophenyl)-2-(piperazin-1-yl)acetonitrile | AA019PCK | MFCD07841699
925549-73-1 | N-[3-(chloromethyl)-4-methyl-4,5-dihydro-1,2,4-thiadiazol-5-ylidene]-N'-phenylbenzenecarboximidamide | AA019PJ3 | MFCD26143672
1182942-88-6 | 2-methyl-3-[(propan-2-ylsulfanyl)methyl]aniline | AA019PPI | MFCD12801197
929974-06-1 | 6-methoxy-4-(trifluoromethyl)quinoline-3-carboxylic acid | AA019Q68 | MFCD09040801
1087798-01-3 | 2,2,2-trifluoroethyl N-(3-chloro-4-fluorophenyl)carbamate | AA019QQ1 | MFCD11099802
31694-91-4 | 2-benzyl-2H-1,2,3,4-tetrazol-5-amine | AA019QX5 | MFCD02689458
1258652-21-9 | 3-(Chlorosulfonyl)naphthalene-1-carboxylic acid | AA019RH6 | MFCD17977210
1249028-10-1 | 2-methanesulfonyl-2-methylpropan-1-amine | AA019RQO | MFCD16766479
1351569-73-7 | tert-butyl (2R,4R)-4-hydroxy-2-(hydroxymethyl)pyrrolidine-1-carboxylate | AA019RWQ | MFCD11617834
1042623-69-7
91890-02-7
620570-54-9
391862-71-8
1010910-51-6
21426-90-4
Journal: Bioorganic & medicinal chemistry letters20101101